CUSIP: 87164U201
Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
6,497,690
-
Share change
-
-1,953,198
-
Total reported value
-
$3,910,000
-
Price per share
-
$0.60
-
Number of holders
-
21
-
Value change
-
-$1,213,989
-
Number of buys
-
8
-
Number of sells
-
13
Quarterly Holders Quick Answers
What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2021
-
Previous quarter:
Q1 2021
Recent filing periods for CUSIP 87164U201:
Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q2 2021
As of 30 Jun 2021,
THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,497,690 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Virtu Financial LLC, NORTHERN TRUST CORP, BLAIR WILLIAM & CO/IL, Fisher Asset Management, LLC, MSD Partners, L.P., and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.